Back to Journals » Open Access Rheumatology: Research and Reviews » Volume 4

Melorheostosis associated with peripheral form spondyloarthropathy: new image with 18-fluoride positron emission tomoscintigraphy coupled to computed tomography

Authors Hassani H, Slama, Hayem, Ben ali, Sarda-mantel, Burg, Le Guludec D

Received 29 November 2011

Accepted for publication 5 December 2011

Published 5 January 2012 Volume 2012:4 Pages 1—7

DOI https://doi.org/10.2147/OARRR.S28657

Review by Single anonymous peer review

Peer reviewer comments 2


Hakim Hassani1–3, Jérôme Slama1,3, Gilles Hayem4, Khadija Ben Ali1, Laure Sarda-Mantel1,3, Samuel Burg1,3, Dominique Le Guludec1,3
1Department of Nuclear Medicine, Hôpital Bichat, Paris, France; 2Radiology, Hôpital Robert Debré, Paris, France; 3University Paris VII Denis Diderot, Paris, France; 4Rheumatology, Hôpital Bichat, Paris, France

Abstract: Melorheostosis is a rare benign bone pathology which can be responsible for incapacitating pain and bone deformations. Its imaging abnormalities are often typical. We describe here the case of a patient with melorheostosis involving the lower limbs, associated with a peripheral form of inflammatory spondyloarthropathy, who underwent 18FNa positron emission tomography coupled to a computed tomography scan. Our objective is to present this new image, to show the value of this new modality and emphasize its advantages compared to the 99mTechnetium bone scan.

Keywords: melorheostosis, PET-CT, 18FNa, bone scan, 18F-fluoride

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]